MBX Biosciences Ownership | Who Owns MBX Biosciences?


OverviewForecastFinancialsChart

MBX Biosciences Ownership Summary


MBX Biosciences is owned by 58.05% institutional investors, 2.84% insiders, and 39.11% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 19.89% of MBX shares.

MBX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMBX Biosciences58.05%2.84%39.11%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryBiotech Stocks 382.11%10.55%-292.66%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Frazier life sciences management6.65M19.89%$116.41M
Wellington management group llp4.82M14.42%$84.41M
Orbimed advisors4.00M11.97%$70.05M
Nea management company3.61M10.81%$63.25M
Deep track capital, lp3.15M9.42%$55.13M
Blackrock funding, inc. /de2.92M8.54%$92.09M
Nvp associates2.14M6.39%$37.39M
Ecor1 capital2.12M6.35%$37.16M
Kynam capital management, lp2.00M5.98%$35.00M
Vanguard group1.82M5.32%$57.33M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nvp associates2.14M22.51%$37.39M
Frazier life sciences management6.65M3.49%$116.41M
Nea management company3.61M3.47%$63.25M
Kynam capital management, lp2.00M2.61%$35.00M
Ecor1 capital2.12M1.78%$37.16M
Orbimed advisors4.00M1.65%$70.05M
Deep track capital, lp3.15M1.54%$55.13M
Cormorant asset management, lp1.23M1.48%$21.44M
Parkman healthcare partners773.30K1.41%$13.53M
Opaleye management253.00K0.63%$4.43M

Top Buyers

HolderShares% AssetsChange
Wellington management group llp4.82M0.01%2.56M
Kynam capital management, lp2.00M2.61%2.00M
Ecor1 capital2.12M1.78%973.81K
Blackrock funding, inc. /de2.92M0.00%962.29K
Deep track capital, lp3.15M1.54%961.41K

Top Sellers

HolderShares% AssetsChange
Franklin resources---1.31M
Bioimpact capital---1.29M
Price t rowe associates inc /md/954.73K0.00%-392.18K
Ra capital management---377.84K
Schonfeld strategic advisors282.68K0.03%-348.74K

New Positions

HolderShares% AssetsChangeValue
Kynam capital management, lp2.00M2.61%2.00M$35.00M
Rock springs capital management lp282.62K0.29%282.62K$4.95M
Baker bros. advisors lp277.78K0.04%277.78K$4.86M
Longaeva partners224.43K0.57%224.43K$3.93M
Goelzer investment management221.67K0.32%221.67K$6.99M

Sold Out

HolderChange
Rise advisors-68.00
Comerica bank-76.00
Washington trust advisors-83.00
Srs capital advisors-398.00
Raymond james financial-761.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202581-39.10%19,853,942-58.46%580.30%63-14.86%9-70.00%
Sep 30, 202513042.86%47,138,46527.96%1401.16%7321.67%30100.00%
Jun 30, 20259115.19%36,839,3653.29%1100.97%60-24.05%15-
Mar 31, 20251-1,579,207-4-1---

Recent Insider Transactions


DateNameRoleActivityValue
Oct 20, 2025Hawryluk P. Kent President & CEOBuy$272.79K
Oct 17, 2025Hoerter Steven L.-Buy$264.98K
Sep 26, 2025Heron Patrick J Buy$12.00M
Apr 08, 2025Pescovitz Ora H.-Buy$45.31K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q42-
2025 Q31-
2025 Q21-

MBX Ownership FAQ


Who Owns MBX Biosciences?

MBX Biosciences shareholders are primarily institutional investors at 58.05%, followed by 2.84% insiders and 39.11% retail investors. The average institutional ownership in MBX Biosciences's industry, Biotech Stocks , is 382.11%, which MBX Biosciences falls below.

Who owns the most shares of MBX Biosciences?

MBX Biosciences’s largest shareholders are Frazier life sciences management (6.65M shares, 19.89%), Wellington management group llp (4.82M shares, 14.42%), and Orbimed advisors (4M shares, 11.97%). Together, they hold 46.28% of MBX Biosciences’s total shares outstanding.

Does Blackrock own MBX Biosciences?

BlackRock is not among the top 10 institutional shareholders of MBX Biosciences.

Who is MBX Biosciences’s biggest shareholder by percentage of total assets invested?

Nvp associates is MBX Biosciences’s biggest shareholder by percentage of total assets invested, with 22.51% of its assets in 2.14M MBX Biosciences shares, valued at 37.39M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools